Tag:
AspenBio Pharma
Latest Headlines
Latest Headlines
ALSO NOTED: Gene Logic takes second look at Merck KGaA drugs; Zars mounts IPO;
> A subsidiary of Germany-based Merck KGaA has inked a deal to help reposition and develop several of Gene Logic's potential drugs. The candidates had been subject of previous clinical trials
